T. Rowe Price Associates’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

T. Rowe Price Associates’s Portfolio CEREW Stock Details CEREW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-223,127	Closed	-$3.18M	–	3026
2021 Q2	$3.18M	Sell	223,127 -11,139	-5%	-$55.8K	﹤0.01%	1601
2021 Q1	$989K	Hold	234,266	–	–	﹤0.01%	2054
2020 Q4	$1.32M	Buy	+234,266	New	+$945K	﹤0.01%	1811

T. Rowe Price Associates's CEREW Position: Q3 2021 in Review

T. Rowe Price Associates sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 223,127 shares — an estimated $3.18M sold.

T. Rowe Price Associates first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $3.18M in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

T. Rowe Price Associates reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
T. Rowe Price Associates sold 223,127 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $3.18M.
T. Rowe Price Associates first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
T. Rowe Price Associates's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $3.18M in Q2 2021.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.